Sol J. Barer, Director at NexImmune, Inc. (NEXI), bought 400,000 shares at $0.41 ($164K) on 2023-03-30, disclosed to the SEC on 2023-03-31.
Open-market purchase of $164k NEXI by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| Filing → |
| NEXI | BUY | 2022-03-24 | $27K | — | Filing → |
| NEXI | BUY | 2022-03-23 | $72K | — | Filing → |
| NEXI | BUY | 2022-03-22 | $128K | — | Filing → |